Author Correction: BHMT polymorphism and susceptibility to PTE in Chinese patients
W.-H. Zhang, S.-M. Zhao, J.-F. Guo, Y.-P. Liu, Y.-Q. Jiang Department of Cardiovascular Medicine, the First Hospital of Jilin University, Changchun, Jilin Province, China
Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (9): 4098-4102. DOI: 10.26355/eurrev_202305_32317-PMID: 37203835-published online on May 15, 2023.
After publication, the authors applied a correction in the Funding section. The section has been amended as follows:
This study was supported by the research program of Jilin Provincial Science and Technology Department (No. 20190201011J).
There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadBHMT polymorphism and susceptibility to PTE in Chinese patients
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
W.-H. Zhang, S.-M. Zhao, J.-F. Guo, Y.-P. Liu, Y.-Q. Jiang
Author Correction: BHMT polymorphism and susceptibility to PTE in Chinese patients
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 13
Pages: 5947-5947
DOI: 10.26355/eurrev_202307_32944